P01CA59350/CA/NCI NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
1995	1
2001	1
2004	1
2005	1
2008	2
2009	2
2011	2
2012	1
2013	1
2024	0

1

Modulation of GITR for cancer immunotherapy.

Schaer DA, Murphy JT, Wolchok JD. Schaer DA, et al. Curr Opin Immunol. 2012 Apr;24(2):217-24. doi: 10.1016/j.coi.2011.12.011. Epub 2012 Jan 12. Curr Opin Immunol. 2012. PMID: 22245556 Free PMC article. Review.

2

Hiding the road signs that lead to tumor immunity.

Schaer DA, Lesokhin AM, Wolchok JD. Schaer DA, et al. J Exp Med. 2011 Sep 26;208(10):1937-40. doi: 10.1084/jem.20111856. J Exp Med. 2011. PMID: 21948803 Free PMC article. Review.

3

Mechanisms of immunization against cancer using chimeric antigens.

Engelhorn ME, Guevara-Patiño JA, Merghoub T, Liu C, Ferrone CR, Rizzuto GA, Cymerman DH, Posnett DN, Houghton AN, Wolchok JD. Engelhorn ME, et al. Mol Ther. 2008 Apr;16(4):773-81. doi: 10.1038/mt.2008.8. Epub 2008 Feb 26. Mol Ther. 2008. PMID: 18301399 Free PMC article.

4

Lentivirus-transduced human monocyte-derived dendritic cells efficiently stimulate antigen-specific cytotoxic T lymphocytes.

Dyall J, Latouche JB, Schnell S, Sadelain M. Dyall J, et al. Blood. 2001 Jan 1;97(1):114-21. doi: 10.1182/blood.v97.1.114. Blood. 2001. PMID: 11133750 Free article.

5

Expression of constitutively active Notch4 (Int-3) modulates myeloid proliferation and differentiation and promotes expansion of hematopoietic progenitors.

Ye Q, Shieh JH, Morrone G, Moore MA. Ye Q, et al. Leukemia. 2004 Apr;18(4):777-87. doi: 10.1038/sj.leu.2403291. Leukemia. 2004. PMID: 14961038

6

Langerhans cells derived from genetically modified human CD34+ hemopoietic progenitors are more potent than peptide-pulsed Langerhans cells for inducing antigen-specific CD8+ cytolytic T lymphocyte responses.

Yuan J, Latouche JB, Reagan JL, Heller G, Riviere I, Sadelain M, Young JW. Yuan J, et al. J Immunol. 2005 Jan 15;174(2):758-66. doi: 10.4049/jimmunol.174.2.758. J Immunol. 2005. PMID: 15634896

7

GITR pathway activation abrogates tumor immune suppression through loss of regulatory T cell lineage stability.

Schaer DA, Budhu S, Liu C, Bryson C, Malandro N, Cohen A, Zhong H, Yang X, Houghton AN, Merghoub T, Wolchok JD. Schaer DA, et al. Cancer Immunol Res. 2013 Nov;1(5):320-31. doi: 10.1158/2326-6066.CIR-13-0086. Cancer Immunol Res. 2013. PMID: 24416730 Free PMC article.

8

Aberrant tissue localization of fungus-specific CD4+ T cells in IL-10-deficient mice.

Rivera A, Collins N, Stephan MT, Lipuma L, Leiner I, Pamer EG. Rivera A, et al. J Immunol. 2009 Jul 1;183(1):631-41. doi: 10.4049/jimmunol.0900396. J Immunol. 2009. PMID: 19542472 Free PMC article.

9

Self-antigen-specific CD8+ T cell precursor frequency determines the quality of the antitumor immune response.

Rizzuto GA, Merghoub T, Hirschhorn-Cymerman D, Liu C, Lesokhin AM, Sahawneh D, Zhong H, Panageas KS, Perales MA, Altan-Bonnet G, Wolchok JD, Houghton AN. Rizzuto GA, et al. J Exp Med. 2009 Apr 13;206(4):849-66. doi: 10.1084/jem.20081382. Epub 2009 Mar 30. J Exp Med. 2009. PMID: 19332877 Free PMC article.

10

Rejection of mouse melanoma elicited by local secretion of interleukin-2: implicating macrophages without T cells or natural killer cells in tumor rejection.

Hara I, Nguyen H, Takechi Y, Gansbacher B, Chapman PB, Houghton AN. Hara I, et al. Int J Cancer. 1995 Apr 10;61(2):253-60. doi: 10.1002/ijc.2910610219. Int J Cancer. 1995. PMID: 7705956

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

12 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year